Seroprevalence of Leptospirosis in Val Müstair, Switzerland

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions
LeptospirosisHepatitis E Virus InfectionTularemia
Interventions
OTHER

Blood sample collection

Blood sample collection (at baseline and approximately two years after baseline). Enzyme-linked immunosorbent assays will be used to screen for IgG and IgM antibodies directed against the three pathogens (Leptospirosis, Tularemia, Hepatitis E).

OTHER

Data collection

Data collection on sociodemographic questions e.g. profession, leisure activities, animal contact

Trial Locations (2)

4031

University Hospital Basel, Division of Internal Medicine, Basel

7536

Center da sanda Val Muestair, Val Müstair

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

collaborator

Kantonsspital St. Gallen, St. Gallen, Switzerland

UNKNOWN